Broderick Brian C - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 8 filers reported holding NOVOZYMES A S DKK 2.0 in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Broderick Brian C ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q3 2023$815,558
-36.2%
20,259
-26.4%
0.22%
-33.2%
Q2 2023$1,277,661
-10.4%
27,509
-1.8%
0.34%
-15.8%
Q1 2023$1,426,094
-9.2%
28,009
-10.0%
0.40%
-14.2%
Q4 2022$1,570,931
-0.3%
31,109
-0.5%
0.47%
-5.5%
Q3 2022$1,576,000
-19.3%
31,259
-4.1%
0.49%
-16.7%
Q2 2022$1,953,000
-22.3%
32,609
-10.9%
0.59%
-7.8%
Q1 2022$2,513,000
-25.1%
36,584
-10.6%
0.64%
-20.4%
Q4 2021$3,356,000
-29.3%
40,934
-41.1%
0.81%
-36.4%
Q3 2021$4,750,000
-24.1%
69,519
-16.5%
1.27%
-23.8%
Q2 2021$6,261,000
+8.6%
83,264
-7.8%
1.66%
+0.2%
Q1 2021$5,767,000
-2.6%
90,289
-12.7%
1.66%
-5.6%
Q4 2020$5,920,000
-10.8%
103,399
-2.1%
1.76%
-16.8%
Q3 2020$6,636,000
+8.0%
105,649
-0.9%
2.11%
+3.3%
Q2 2020$6,143,000
+25.9%
106,579
-0.5%
2.04%
+5.9%
Q1 2020$4,881,000
-6.9%
107,125
-0.3%
1.93%
+13.7%
Q4 2019$5,241,000
+16.4%
107,425
+0.0%
1.70%
+9.6%
Q3 2019$4,504,000
-10.6%
107,419
-0.9%
1.55%
-12.1%
Q2 2019$5,040,000
+1.3%
108,4120.0%1.76%
-0.8%
Q1 2019$4,973,000
+5.2%
108,412
+2.1%
1.78%
-10.7%
Q4 2018$4,728,000
-20.1%
106,187
-1.9%
1.99%
-0.9%
Q3 2018$5,921,000
+8.1%
108,202
+0.1%
2.01%
+0.2%
Q2 2018$5,479,000
-2.2%
108,147
-0.5%
2.00%
-4.6%
Q1 2018$5,601,000
-11.5%
108,647
-2.2%
2.10%
-9.1%
Q4 2017$6,326,000
+1.8%
111,054
-8.5%
2.31%
+2.9%
Q3 2017$6,217,000
+17.7%
121,402
+0.6%
2.24%
+14.8%
Q2 2017$5,282,000
+15.6%
120,665
+4.6%
1.95%
+4.8%
Q1 2017$4,570,000
+21.3%
115,312
+5.5%
1.86%
+14.1%
Q4 2016$3,769,000
-19.1%
109,307
+3.1%
1.63%
-17.8%
Q3 2016$4,661,000
-9.3%
105,995
-0.8%
1.99%
-8.2%
Q2 2016$5,141,000
+7.5%
106,895
+0.4%
2.16%
+4.4%
Q1 2016$4,784,000
-5.7%
106,430
+0.9%
2.07%
-8.8%
Q4 2015$5,075,000
+11.5%
105,440
+0.9%
2.27%
+7.7%
Q3 2015$4,552,000
-3.4%
104,480
+5.4%
2.11%
+5.0%
Q2 2015$4,712,000
+3.4%
99,145
-0.5%
2.01%
+6.1%
Q1 2015$4,559,000
+12.1%
99,600
+3.4%
1.89%
+9.8%
Q4 2014$4,067,000
+1.4%
96,370
+4.3%
1.72%
-3.4%
Q3 2014$4,009,000
-13.4%
92,386
+0.0%
1.78%
-15.9%
Q2 2014$4,632,000
+12.6%
92,356
-1.3%
2.12%
+4.9%
Q1 2014$4,113,000
+2.4%
93,546
-1.7%
2.02%
+1.1%
Q4 2013$4,017,000
+14.2%
95,196
+3.6%
2.00%
+2.0%
Q3 2013$3,516,000
+33.9%
91,906
+12.1%
1.96%
+24.9%
Q2 2013$2,625,000
-5.2%
82,001
+0.3%
1.57%
-4.5%
Q1 2013$2,770,000
+26.5%
81,716
+4.9%
1.64%
+5.9%
Q4 2012$2,190,00077,8811.55%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q1 2022
NameSharesValueWeighting ↓
Delaney Dennis R 32,907$1,897,0002.54%
Fayerweather Charles 22,858$1,318,0002.31%
SOMERVILLE KURT F 206,900$11,927,0002.20%
Gardiner Nancy B 22,350$1,288,0002.13%
Broderick Brian C 106,579$6,143,0002.04%
PUZO MICHAEL J 93,960$5,416,0002.03%
Kidder Stephen W 90,846$5,237,0002.00%
Page Arthur B 37,705$2,173,0001.92%
Dempze Nancy E 26,893$1,549,0001.73%
Hemenway Trust Co LLC 206,922$11,927,0001.66%
View complete list of NOVOZYMES A S DKK 2.0 shareholders